According to FutureWise analysis the market for blood product in 2023 was US$ 37.19 billion, and is expected to reach US$ 53.95 billion by 2031 at a CAGR of 4.80%. Blood products are essential therapeutic substances derived from whole blood or obtained through a process known as apheresis. They play a vital role in treating various medical conditions, particularly those related to blood loss,...